Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 9:32:e8.
doi: 10.1017/S2045796023000045.

Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment

S Ali  1   2 , D Santomauro  1   2 , A J Ferrari  1   2 , F Charlson  1   2
Affiliations

Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment

S Ali et al. Epidemiol Psychiatr Sci. .

Abstract

Aims: Cardiometabolic diseases are responsible for the majority of premature deaths in people with schizophrenia. This study aimed to quantify the fatal burden of ischaemic heart disease (IHD), stroke and diabetes attributable to schizophrenia.

Methods: Comparative Risk Assessment methodology from the Global Burden of Disease (GBD) study was used to calculate attributable burden; pooled relative risks (RRs) for IHD, stroke and diabetes were estimated via meta-regression, which were combined with GBD schizophrenia prevalence estimates to calculate the deaths and years of life lost (YLLs) caused by these health outcomes that were attributable to schizophrenia. The proportion of explained all-cause fatal burden and corresponding unexplained burden was also calculated.

Results: The pooled RRs for IHD, stroke and diabetes mortality were 2.36 [95% uncertainty interval (UI) 1.77 to 3.14], 1.86 (95% UI 1.36 to 2.54) and 4.08 (95% UI 3.80 to 4.38) respectively. Schizophrenia was responsible for around 50 000 deaths and almost 1.5 million YLLs globally in 2019 from these health outcomes combined. IHD, stroke and diabetes together explained around 13% of all deaths and almost 11% of all YLLs attributable to schizophrenia, resulting in 320 660 (95% UI 288 299 to 356 517) unexplained deaths and 12 258 690 (95% UI 10 925 426 to 13 713 646) unexplained YLLs.

Conclusions: Quantifying the physical disease burden attributable to schizophrenia provides a means of capturing the substantial excess mortality associated with this disorder within the GBD framework, contributing to an important evidence base for healthcare planning and practice.

Keywords: Epidemiology; health outcomes; mental health; schizophrenia.

PubMed Disclaimer

References

    1. Ali S, Santomauro D, Ferrari AJ and Charlson F (2022) Excess mortality in severe mental disorders: a systematic review and meta-regression. Journal of Psychiatric Research 149, 97–105. - PubMed
    1. Castagnini A, Foldager L and Bertelsen A (2013) Excess mortality of acute and transient psychotic disorders: Comparison with bipolar affective disorder and schizophrenia. Acta Psychiatrica Scandinavica 128, 370–375. - PubMed
    1. Correll CU, Solmi M, Croatto G, Schneider LK, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H and Tiihonen J (2022) Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry 21, 248–271. - PMC - PubMed
    1. Crump C, Winkleby MA, Sundquist K and Sundquist J (2013) Comorbidities and mortality in persons with schizophrenia: A Swedish national cohort study. American Journal of Psychiatry 170, 324–333. - PubMed
    1. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI and Moller HJ (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry 24, 412–424. - PubMed